New Drug For Mucopolysaccharidosis Gets FDA Approval For Study
Source: Pixabay

New Drug For Mucopolysaccharidosis Gets FDA Approval For Study

The FDA approved a human study to be conducted by Swedish Orphan Biovitrum AB to treating mucopolysaccharidosis type lllA patients with a new drug called SOB1003, reported European Pharmaceutical Review. Not only…

Continue Reading New Drug For Mucopolysaccharidosis Gets FDA Approval For Study